Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2017 2018 2019 2020 2021 2022 2023 2024
Months
January February March April May June July August September October November December
Previous Archive
09 April 2018 Photo Supplied
CGAS awards second AS scholarship Chetima Melchisedek
Chètima Melchisedek is the recipient of the UFS/AS Young African Scholarship is planning a visit to the UFS Centre for Gender and Africa Studies in 2019.
Chétima Melchisedek from the University of Ottawa, Canada, has been awarded the 2018 UFS/AS Young African Scholarship. “An award like the UFS/AS Young African Scholar is a great accomplishment for a young scholar,” said Chétima.

Melchisedek is the 2018 Gordon F Henderson Fellow at the Human Rights Research and Education Centre at the University of Ottawa and is affiliated  with the University of Maroua in Cameroon. “I am also very happy and honoured to be affiliated to the Centre for Gender and Africa Studies (CGAS) at the UFS. To be able to work with the university is a privilege I am delighted to receive.”

He says the disciplines within Africa studies should be researched by Africans from the continent. “My aim was also to be able to share my knowledge through publications in established journals. In fact, today, this is the only way to be recognised as an authoritative voice on African studies from Africa,” he said.

Scholarship provides platform to young researchers 
The Young African Scholar Award is an initiative by the Centre for Gender and Africa Studies. It seeks to strengthen efforts to promote internationally recognised African scholarship within Africa Studies.   

The programme provides young researchers the platform to publish their work and to build an international network with organisations such as the German Institute of Global and Area Studies (GIGA), the German African Studies Association (Vereinigung von Afrikanisten in Deutschland/VAD), and the UFS Centre for Gender and Africa Studies.

“The award is given to the best, publishable research article contribution by an emerging African scholar to the prestigious African Spectrum journal,” said Dr Stephanie Cawood, Acting Director of CGAS. The prerequisite for the award is that applicants must be from Africa or affiliated with African institutions.  

As part of the prize, the winner receives a three-year affiliation as research fellow with the UFS GGAS and prize money of R5000.

News Archive

Researchers receive study grant for research into Congo Fever
2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept